Practical
Safety and what to expect
Most of these treatments are reasonably well tolerated in the short term. That is not the same as being free of risk, and the risks differ enormously between an infusion under sedation and a light placed on the scalp.
Before anything is given
- Get the plan in writing — product, dose, route, number of sessions, cost, and who is responsible if something goes wrong.
- Check who is giving it. For any procedure needing sedation, anaesthetic cover and resuscitation facilities are not optional extras.
- Tell them everything your child takes, including antiseizure medicines, anticoagulants and supplements.
- Declare epilepsy explicitly before magnetic stimulation, and metal implants or cochlear devices before anything magnetic.
- Ask what is not included — follow-up, management of complications, repeat scans.
Risks that are specific rather than general
| Treatment | The risk that actually matters |
|---|---|
| Cell infusion | Sedation and the delivery procedure itself; infusion reactions; infection if the product was not made to pharmaceutical standard. |
| Intrathecal delivery | Lumbar puncture: headache, bleeding, infection. Higher stakes than an intravenous line, and not always necessary. |
| Exosome products | Contamination. Serious infections have been traced to unlicensed preparations given in private clinics. |
| Photobiomodulation | Low direct risk. Protect the eyes. The real cost is time and money diverted from therapies with better evidence. |
| Magnetic stimulation | Seizure — rare, and the reason published paediatric parameter limits exist. Also scalp pain, headache, hearing protection. |
Measuring whether anything changed
This is where families are most often let down, and it is entirely fixable. Decide the measurement before the first session, with someone who is not selling the treatment.
- Pick one or two outcomes that matter in daily life — sitting unsupported for a minute, drinking from an open cup, settling at night, using ten signs reliably.
- Use a standard scale where one exists, scored by the same therapist each time.
- Record a short video at home before starting, under the same conditions you will repeat later.
- Set the review date in advance, and keep it even if the treatment is still running.
Children with developmental conditions change over months regardless. Without a baseline and a scale, there is no way to tell improvement from growth, from a good period, or from the intensive therapy that usually accompanies these programmes.
What a realistic good result looks like
Where benefit has been shown in controlled studies, it is typically a modest shift on a functional scale — a little more head control, a slightly longer attention span, a hand that participates more. These are worth having. They are not what most promotional material implies, and a family prepared for the real size of the effect is far less likely to be hurt by it.
When to stop
- The agreed review date arrives and the agreed outcome has not moved.
- Your child is distressed by the procedures in a way that is not settling.
- The plan keeps extending without a new reason.
- Standard therapy is being squeezed out to make room.
See also: judging a therapy and the evidence table.